Lipogems System for Knee Osteoarthritis

About Lipogems International

Lipogems International is a clinical-stage medical technology company pioneering a novel approach in regenerative medicine. Its core innovation is the Lipogems® system, a closed, minimally invasive device that harvests and processes a patient's adipose tissue to concentrate regenerative cells and factors without enzymatic manipulation or additives. The company is advancing its technology through clinical studies, including a pivotal U.S. FDA IDE trial for knee osteoarthritis, and has established a global commercial footprint for its device outside the United States. With over 140 peer-reviewed publications, Lipogems is positioning its autologous, point-of-care therapy as a safe and effective alternative or adjunct to traditional surgical interventions.

Therapeutic Areas

Other Knee Osteoarthritis Drugs